Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.31794
Abstract: A 79-year old male was admitted to hospital for weight loss and polyarthritis. Examination revealed warmth, erythema and swelling of the left metacarpophalangeal joints, wrist, right shoulder and ankle. The CRP was elevated at 109… read more here.
Keywords: polyarthritis hepatocellular; hepatocellular carcinoma; paraneoplastic polyarthritis; polyarthritis ... See more keywords
Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab.
Sign Up to like & getrecommendations! Published in 2020 at "European urology"
DOI: 10.1016/j.eururo.2020.06.061
Abstract: Antibiotic effects on the gut microbiota may negatively impact survival with immune checkpoint inhibitors (ICIs). However, there is minimal evidence regarding whether antibiotic impacts are specific to ICIs or impacts in urothelial carcinoma (UC). In… read more here.
Keywords: treated atezolizumab; use; antibiotic use; urothelial carcinoma ... See more keywords
Peritoneal Metastases From Prostate Carcinoma Treated With 177Lu-PSMA-I&T.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004577
Abstract: ABSTRACT A 71-year-old man was referred for 177Lu-PSMA therapy. He had metastatic castration-resistant prostate cancer, progressive on several treatment lines, with current PSA 260 μg/L and deteriorating condition. CT showed ascites with omental and peritoneal… read more here.
Keywords: carcinoma treated; peritoneal metastases; 177lu psma; metastases prostate ... See more keywords
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15995
Abstract: Background/Aim: To identify predictors of severe adverse events (≥grade 3) in patients with advanced hepatocellular carcinoma treated with lenvatinib. Patients and Methods: Of 41 patients, 25 and 16 were stratified into the severe and non-severe… read more here.
Keywords: carcinoma treated; hepatocellular carcinoma; advanced hepatocellular; severe adverse ... See more keywords
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14235834
Abstract: Simple Summary Immunotherapy is now the standard front-line therapy for patients with advanced hepatocellular carcinoma. However, there remains a substantial proportion of patient who do not respond to this treatment, and few predictive and prognostic… read more here.
Keywords: carcinoma treated; hepatocellular carcinoma; prognostic biomarkers; carcinoma ... See more keywords